These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30860874)

  • 41. Neuroprotective effects of liraglutide against inflammation through the AMPK/NF-κB pathway in a mouse model of Parkinson's disease.
    Cao B; Zhang Y; Chen J; Wu P; Dong Y; Wang Y
    Metab Brain Dis; 2022 Feb; 37(2):451-462. PubMed ID: 34817756
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Liraglutide ameliorates palmitate-induced endothelial dysfunction through activating AMPK and reversing leptin resistance.
    Li N; Zhao Y; Yue Y; Chen L; Yao Z; Niu W
    Biochem Biophys Res Commun; 2016 Sep; 478(1):46-52. PubMed ID: 27457805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metformin and liraglutide ameliorate high glucose-induced oxidative stress via inhibition of PKC-NAD(P)H oxidase pathway in human aortic endothelial cells.
    Batchuluun B; Inoguchi T; Sonoda N; Sasaki S; Inoue T; Fujimura Y; Miura D; Takayanagi R
    Atherosclerosis; 2014 Jan; 232(1):156-64. PubMed ID: 24401231
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Liraglutide, a glucagon-like peptide-1 receptor agonist, induces ADAM10-dependent ectodomain shedding of RAGE via AMPK activation in human aortic endothelial cells.
    Baek CH; Kim H; Moon SY; Yang WS
    Life Sci; 2022 Mar; 292():120331. PubMed ID: 35041837
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4.
    Arakawa M; Mita T; Azuma K; Ebato C; Goto H; Nomiyama T; Fujitani Y; Hirose T; Kawamori R; Watada H
    Diabetes; 2010 Apr; 59(4):1030-7. PubMed ID: 20068138
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glucagon-like peptide-1 (GLP-1) analog liraglutide inhibits endothelial cell inflammation through a calcium and AMPK dependent mechanism.
    Krasner NM; Ido Y; Ruderman NB; Cacicedo JM
    PLoS One; 2014; 9(5):e97554. PubMed ID: 24835252
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The impact of the glucagon-like peptide 1 receptor agonist liraglutide on the streptozotocin-induced diabetic mouse kidney proteome.
    Liljedahl L; Pedersen MH; McGuire JN; James P
    Physiol Rep; 2019 Feb; 7(4):e13994. PubMed ID: 30806030
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The human glucagon-like peptide-1 analogue liraglutide regulates pancreatic beta-cell proliferation and apoptosis via an AMPK/mTOR/P70S6K signaling pathway.
    Miao XY; Gu ZY; Liu P; Hu Y; Li L; Gong YP; Shu H; Liu Y; Li CL
    Peptides; 2013 Jan; 39():71-9. PubMed ID: 23116613
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cilostazol improves high glucose-induced impaired angiogenesis in human endothelial progenitor cells and vascular endothelial cells as well as enhances vasculoangiogenesis in hyperglycemic mice mediated by the adenosine monophosphate-activated protein kinase pathway.
    Tseng SY; Chao TH; Li YH; Liu PY; Lee CH; Cho CL; Wu HL; Chen JH
    J Vasc Surg; 2016 Apr; 63(4):1051-62.e3. PubMed ID: 25595409
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liraglutide enhances glucose transporter 4 translocation via regulation of AMP-activated protein kinase signaling pathways in mouse skeletal muscle cells.
    Li Z; Ni CL; Yao Z; Chen LM; Niu WY
    Metabolism; 2014 Aug; 63(8):1022-30. PubMed ID: 24972503
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liraglutide alleviates high-fat diet-induced kidney injury in mice by regulating the CaMKKβ/AMPK pathway.
    Xuan Y; Ding TT; Mao XL; Pang S; He R; Qin L; Yuan JZ
    Ren Fail; 2024 Dec; 46(1):2351473. PubMed ID: 38915241
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral chromium picolinate impedes hyperglycemia-induced atherosclerosis and inhibits proatherogenic protein TSP-1 expression in STZ-induced type 1 diabetic ApoE
    Ganguly R; Sahu S; Ohanyan V; Haney R; Chavez RJ; Shah S; Yalamanchili S; Raman P
    Sci Rep; 2017 Mar; 7():45279. PubMed ID: 28345659
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term liraglutide ameliorates nigrostriatal impairment via regulating AMPK/PGC-1a signaling in diabetic mice.
    Ma D; Liu X; Liu J; Li M; Chen L; Gao M; Xu W; Yang Y
    Brain Res; 2019 Jul; 1714():126-132. PubMed ID: 30826352
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 6-Gingerol Ameliorates Behavioral Changes and Atherosclerotic Lesions in ApoE
    Wang S; Tian M; Yang R; Jing Y; Chen W; Wang J; Zheng X; Wang F
    Cardiovasc Toxicol; 2018 Oct; 18(5):420-430. PubMed ID: 29605868
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects.
    Palleria C; Leo A; Andreozzi F; Citraro R; Iannone M; Spiga R; Sesti G; Constanti A; De Sarro G; Arturi F; Russo E
    Behav Brain Res; 2017 Mar; 321():157-169. PubMed ID: 28062257
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Balasubramide derivative 3C attenuates atherosclerosis in apolipoprotein E-deficient mice: role of AMPK-STAT1-STING signaling pathway.
    Cai D; Liu H; Wang J; Hou Y; Pang T; Lin H; He C
    Aging (Albany NY); 2021 Apr; 13(8):12160-12178. PubMed ID: 33901014
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Liraglutide Inhibits Hepatitis C Virus Replication Through an AMP Activated Protein Kinase Dependent Mechanism.
    Lee MY; Chen WC; Hsu WH; Chen SC; Lee JC
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540136
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Liraglutide protects against nonalcoholic fatty liver disease in ApoE knockout mice with high-fat diet and silenced Acrp30 by increasing AMPK].
    Zhao XY; Zhang LL; Suolang QZ; Yang GY; Li L; Li SB; Chen WW
    Zhonghua Gan Zang Bing Za Zhi; 2014 Nov; 22(11):849-53. PubMed ID: 25531383
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Knockdown of GSK3β increases basal autophagy and AMPK signalling in nutrient-laden human aortic endothelial cells.
    Weikel KA; Cacicedo JM; Ruderman NB; Ido Y
    Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27534430
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SCAP knockdown in vascular smooth muscle cells alleviates atherosclerosis plaque formation via up-regulating autophagy in ApoE
    Li D; Chen A; Lan T; Zou Y; Zhao L; Yang P; Qu H; Wei L; Varghese Z; Moorhead JF; Chen Y; Ruan XZ
    FASEB J; 2019 Mar; 33(3):3437-3450. PubMed ID: 30462530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.